Key result
Cyclophosphamide treatment in mice chronically infected with T. cruzi increased delayed type hypersensitivity skin thickness and significantly increased the number of heart interstitial dendritic cells.
In a mouse model of chronic Trypanosoma cruzi infection, low-dose cyclophosphamide enhances delayed type hypersensitivity and increases heart interstitial dendritic cells, suggesting their role in regulating the immune response.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for dendritic cell modulation in chronic Chagas; leaves open human translation and clinical relevance.
Acute infection with Trypanosoma cruzi results in intense myocarditis, which progresses to a chronic, asymptomatic indeterminate form. The evolution toward this chronic cardiac form occurs in approximately 30% of all cases of T. cruzi infection. Suppression of delayed type hypersensitivity (DTH) has been proposed as a potential explanation of the indeterminate form. We investigated the effect of cyclophosphamide (CYCL) treatment on the regulatory mechanism of DTH and the participation of heart interstitial dendritic cells (IDCs) in this process using BALB/c mice chronically infected with T. cruzi. One group was treated with CYCL (20 mg/kg body weight) for one month. A DTH skin test was performed by intradermal injection of T. cruzi antigen (3 mg/mL) in the hind-footpad and measured the skin thickness after 24 h, 48 h and 72 h. The skin test revealed increased thickness in antigen-injected footpads, which was more evident in the mice treated with CYCL than in those mice that did not receive treatment. The thickened regions were characterised by perivascular infiltrates and areas of necrosis. Intense lesions of the myocardium were present in three/16 cases and included large areas of necrosis. Morphometric evaluation of lymphocytes showed a predominance of TCD8 cells. Heart IDCs were immunolabelled with specific antibodies (CD11b and CD11c) and T. cruzi antigens were detected using a specific anti-T. cruzi antibody. Identification of T. cruzi antigens, sequestered in these cells using specific anti-T. cruzi antibodies was done, showing a significant increase in the number of these cells in treated mice. These results indicate that IDCs participate in the regulatory mechanisms of DTH response to T. cruzi infection.
No takes yet. Share an insight, caveat, or question.
The et al. (2013) studied Trypanosoma cruzi infection. Cyclophosphamide vs. No treatment was evaluated on Delayed type hypersensitivity (DTH) skin test thickness and heart interstitial dendritic cells (IDCs) participation. Cyclophosphamide treatment in mice chronically infected with T. cruzi increased delayed type hypersensitivity skin thickness and significantly increased the number of heart interstitial dendritic cells.
Synapse has enriched 10 related papers. Consider them for comparative context: